The purpose of this study was to identify trends and factors associated with outcomes of persistent truncus arteriosus (PTA).
Persistent truncus arteriosus (PTA) is an uncommon congenital cardiac malformation accounting for approximately 1.2% of all congenital heart malformations (1). Features of PTA include a single great artery arising from the base of the heart, that supplies systemic, coronary and pulmonary blood flow, together with a ventricular septal defect. Both characteristics are believed to result from failure of proper conotruncal septation. The two main classification systems used to describe the anatomy of PTA are those of Collett & Edwards (1949) and Van Praagh (1965) (2) . The natural history of children born with PTA is such that up to 80% or more die within the first year of life without surgical intervention (1, 3, 4, 5) . The first successful surgical repair of PTA was performed by McGoon, Rastelli and Ongley (6) in 1967. They used an aortic homograft including the aortic valve to establish continuity from the right ventricle (RV) to the pulmonary artery (PA). Since then, various means of reconstruction have been developed, and controversies remain concerning which method is the best to use and at what age surgery should optimally be performed. The main long-term management issues relate to conduit stenosis and truncal valve incompetence and stenosis. The necessary reoperations to address these complications are associated with further risk of mortality and morbidity. Risk factors and outcomes related to this lesion have been incompletely defined. We therefore sought to determine the changing patterns of mortality and morbidity related to PTA at a single institution and to define potential factors associated with outcomes related to management.
METHODS
Study population. All patients with a diagnosis of PTA were identified in the Cardiology Database of the Division of Cardiology, The Hospital for Sick Children, and were included in the present study. The diagnosis was verified in the medical record for all patients, and patients who were miscoded and did not have PTA were excluded.
Measurements. The cardiology and hospital records for all patients were reviewed. Data collected included demographics, anatomic diagnoses, status at presentation, surgeries, interventional catheterization procedures and follow-up status.
Data analysis. Data are described as frequencies, medians with ranges and means with standard deviations. Where there is missing data, the available values are given. Changes in characteristics, management and outcomes over time were sought by creating four groups based on birth date: 1953-1967, 1968 -1977, 1978 -1987 and 1988 -1997 . Differences between these groups were sought using Mantel Haentzel chi-square tests, Kruskal-Wallis analysis of variance and analysis of variance. Associations between the number of PTA valve cusps and presence, and severity of stenosis and regurgitation were sought with MantelHaentzel chi-square tests. Severity of stenosis was related to severity of regurgitation with gamma coefficient. Factors associated with hospital mortality after PTA repair were sought with Fisher exact tests, chi-square tests, KruskalWallis analysis of variance and Student t tests. KaplanMeier estimates of freedom from initial RV to PA conduit replacement were plotted, and factors associated with decreased time to initial conduit replacement were tested with log rank and Wilcoxon tests. A p Ͻ 0.05 was set as the level of statistical significance.
RESULTS

Patient Characteristics
Demographics. From the Cardiology Database, 205 patients were identified and verified with the diagnosis of PTA, and date of birth ranged from January 1, 1953 to December 31, 1997. Cases were grouped into birth cohorts as follows: 1953-1967, n ϭ 13; 1968 -1977, n ϭ 42; 1978 -1987, n ϭ 69 and 1988 -1997, n ϭ 81. There were 76 males and 129 females.
Presentation. The median age at presentation (n ϭ 202) was 4 days with a range from birth to 5.8 years. Median age of participants at presentation became progressively younger with subsequent birth cohorts (p Ͻ 0.001) as follows: 1953-1967, 92 days (n ϭ 13); 1968 -1977, 17 days (n ϭ 41); 1978 -1987, 2 days (n ϭ 68) and 1988 -1997, 1 day (n ϭ 80). Clinical signs at presentation (n ϭ 201) were congestive heart failure in 117 patients (58%), cyanosis in 89 (44%), respiratory infection or distress in 33 (16%), failure to thrive in 7 (3%), cardiac arrhythmias in 3 (1%) and clubbing of fingers and toes in two patients (1%). One patient presented in a moribund state. The methods used to establish the diagnosis (n ϭ 200) consisted of echocardiography alone in 103 patients (51%), cardiac catheterization alone in 63 (31%), both echocardiography and catheterization in 29 (15%), echocardiography with magnetic resonance imaging in 2 (1%) and at postmortem examination in 3 patients (2%).
The median age at diagnosis (n ϭ 202) was 7 days with a range from 22 days before birth at fetal echocardiography to 15 years. Median age at diagnosis became progressively younger with subsequent birth cohorts (p Ͻ 0.001) as follows: 1953-1967, 8 months (n ϭ 13); 1968 -1977, 42 days (n ϭ 41); 1978 -1987, 7 days (n ϭ 68) and 1988 -1997, 2 days (n ϭ 80).
Cardiac anatomy. The specific PTA anatomy of the patients (n ϭ 202) was as follows: single pulmonary trunk and ascending aorta arising from the PTA in 140 patients (69%), right and left PAs arising from separate orifices close together from the dorsal wall of the PTA in 41 (20%), one or both PAs arising from the separate orifices at the lateral aspects of the PTA in 14 (7%), the branch PAs immediately adjacent to one another with a common orifice but no common trunk following attachment from the PTA in 4 (2%), no true branch PAs arising from the PTA (Collett and Edwards Type 4) in 2 (1%) and in one patient, the right PA arose from the posterior wall of the PTA with the left PA arising from a main PA from the PTA (Ͻ1%). Other associated cardiovascular anomalies are described in Table 1 . The reported prevalence of interatrial communications reflects only those defects noted at echocardiography, cardiac catheterization, surgery or autopsy and may be an underestimation of defects that may not have been adequately imaged or that closed spontaneously.
The number of PTA valve leaflets (n ϭ 156) were two in 11 patients (7%), three in 85 (54%), four in 58 (37%), five in 1 (1%) and six in 1 patient (1%). Persistent truncus arteriosus valve regurgitation was described in 123 (69%) of 178 patients and was graded subjectively at the time of either echocardiography or cardiac catheterization in 115 patients as mild in 88 (77%), moderate in 22 (19%) and severe in 5 patients (4%). Persistent truncus arteriosus valve stenosis was described in 75 (56%) of 135 patients and was graded subjectively in 72 patients as mild in 49 (68%), moderate in 11 (15%) and severe in 12 patients (17%).
Persistent truncus arteriosus valve abnormalities significantly impacted on the incidence of both valve stenosis and regurgitation. Moderate to severe valve stenosis was more likely in patients with two valve cusps (2 of 9; 22%) or four or more valve cusps (14 of 44; 32%) than it was in those with three valve cusps (5 of 65; 8%; p ϭ 0.005). Moderate to severe valve regurgitation was more likely in patients with four or more valve cusps (17 of 57; 30%) than it was in those with two valve cusps (0 of 9; 0%) or three valve cusps ( significantly correlated with the degree of valve regurgitation (gamma 0.526; error 0.099).
Noncardiac abnormalities. Noncardiac abnormalities were described in 81 patients and included DiGeorge syndrome (n ϭ 22), dysmorphic features (n ϭ 18), neonatal seizures (n ϭ 10), cleft palate (n ϭ 6), renal abnormalities (n ϭ 6), bilateral choanal atresia (n ϭ 3), cardiofacial syndrome (n ϭ 3), esophageal atresia (n ϭ 2), tracheoesophageal fistula (n ϭ 1), Hemophilia A (n ϭ 1), chest wall anomalies (n ϭ 1), omphalocele (n ϭ 1), quadriplegia (n ϭ 1), absent corpus callosum (n ϭ 1), Noonan syndrome (n ϭ 1) and Potter syndrome (n ϭ 1).
Management and Outcomes
The management and survivorship for the patients is shown in Figure 1 . The management and status of three patients is unknown.
Presurgical outcomes.
No surgery was performed in 42 (21%) patients; 31 (74%) of these patients subsequently died at a median age of 11 days (range: birth to 19.4 years), with 27 patients dying before 6 months of age. The median interval from diagnosis to death in these patients was 3 days (range: Ͻ1 day to 18.9 years), with one patient having been diagnosed at autopsy. patients for which this could be ascertained, with a mean duration (available for 81 of the 90 patients) of 38 Ϯ 20 min. The RV to PA conduit was valved in 144/144 patients, and the type of conduit (n ϭ 144) was a xenograft in 43% (Hancock in 61%, Polystan in 36% and Goretex in 3%), cryopreserved aortic homograft in 37%, cryopreserved pulmonary homograft in 19% and an autograft (direct tissue connection) in 1%. In addition to repair of interrupted aortic arch where applicable at the time of PTA repair, six patients had replacement of the PTA valve with two additional patients having repair of the PTA valve.
Hospital mortality. There were 74 deaths (50%) before hospital discharge, with 43 deaths either in the operating room or within the first 24 h after surgery (range up to 14 days). Cumulative deaths versus consecutive repairs is shown in Figure 2 . Causes of death included pulmonary hemorrhage in one patient, intracranial hemorrhage in one and cardiac tamponade in one patient, with the remainder of patients dying from circulatory failure. Hospital mortality Factors associated with hospital mortality with PTA repair were sought (Table 2) . Hospital mortality was not significantly related to preoperative PTA anatomy (PA connections), PTA valve stenosis or regurgitation, number of PTA valve cusps, presence of a major associated cardiac anomaly, previous palliative procedures, preoperative management in the intensive care unit or use of mechanical ventilation, presence of ischemic changes on the preoperative electrocardiogram, age at PTA repair or cardiopulmonary bypass time. Increased hospital mortality was significantly related to earlier date of surgical repair in the overall experience. Late mortality. There were 11 late deaths (15%) in the 74 hospital survivors after PTA repair, which occurred at a median interval after repair (n ϭ 10) of 5.5 months (range, 1.8 months to 5.3 years). Cause of late death was related to pulmonary infection in three patients, pulmonary hypertension in one, cardiac failure in one, arrhythmia in one, thrombosis of the conduit valve in one, hospital death after conduit replacement in one and was unknown in three patients. Kaplan Meier survival estimates after hospital discharge in survivors after repair are shown in Figure 3 , with survival of 83% up to 20.3 years. Survival after hospital discharge was not significantly related to demographics, PTA and PTA valve anatomy, previous palliative procedures, age and date of PTA repair or cardiopulmonary bypass time.
Subsequent procedures. Persistent truncus arteriosus valve replacement was required in four patients, with a second valve replacement required in one of these patients. Conduit replacement was required during follow-up procedures in 34 of the 74 survivors (46%), with Kaplan-Meier estimates of freedom from initial conduit replacement shown in Figure  4 . A second conduit replacement was performed in seven patients with one patient requiring a third replacement. Freedom from initial conduit replacement was not significantly related to patient age or date of PTA repair but was significantly increased with increasing size of initial conduit placed (log rank test p ϭ 0.02; Wilcoxon test p ϭ 0.01). This was also significantly related to the type of initial homograft material (log rank test p ϭ 0.002, Wilcoxon test p ϭ 0.008), with pulmonary homografts lasting the longest, aortic homografts next followed by xenografts (Fig. 5 ).
Interventional cardiac catheterization was performed in 31 patients (42%), initially for branch PA stenoses in 19 patients, for conduit or conduit valve stenosis in 9 and for both in 4 patients, with 1 patient having balloon dilation of aortic arch obstruction. Subsequent additional interventional catheterization procedures were performed in 13 of these patients. (Fig. 6) .
DISCUSSION
Natural history. The natural history of PTA in the presurgical era has not been well-documented. In 1957, Anderson et al. (7) described a group of 14 patients with PTA, with 11 of them diagnosed at autopsy and 3 confirmed at surgery. The median age at diagnosis was 3 months. In 1976, Calder et al. (8) noted that the diagnosis in their study group of 100 patients was still primarily made at autopsy (79%) at a median age of 5 weeks. Most patients died in early infancy (7) (8) (9) (10) . In our study, we found that 31 of 42 patients (74%) that had no surgery died at a median age of 11 days with a range from birth to 19.4 years, with 84% (26/31) being younger than 6 months old. Hicken et al. (9) first reported a case of a woman with PTA that died at the age of 38 years. Three published long-term survival studies of unrepaired patients report mortality rates of 61% with death occurring at a median age of 1.5 years (10), 81% with a median age of 5 weeks (8) and 100% with a median age of 4.5 months (7), respectively.
Palliative surgical procedures. The role of palliative surgical procedures such as PA banding to manage PTA has changed considerably during the years. Trends toward decreased palliative procedures were accompanied by trends toward younger age at PTA repair. In the past, PTA patients underwent PA banding if medical treatment failed to control congestive heart failure (5), often with a view to PTA repair at an older age. Palliation with PA banding is currently not believed to have any advantages (8, 11) and is associated with high mortality rates (4, 5, (12) (13) (14) (15) (16) Age at repair. Age at PTA repair has been decreasing over the years. Overall median age at repair in this study was 38 days, but decreased significantly with subsequent birth cohorts from 11.2 years to 12 days. This trend is supported in the published literature from the past 30 years, with reported median ages ranging from 3.5 months to 7.3 years (1, 3, (17) (18) (19) . More recent studies published in the last 15 years report that age at repair has decreased dramatically, with median ages ranging from 8 to 41 days (11,20 -23) . A possible explanation for this trend is the improvements in neonatal cardiothoracic surgery combined with a desire to prevent pulmonary vascular obstructive disease in the patients who are at very high risk.
Hospital mortality after PTA repair. Early mortality rates after PTA repair vary considerably in previous series. Sano et al. (23) reported no early mortality in a series of seven patients undergoing repair from 1985-1989. Other series from a similar time period report early mortality rates of 9% (1986 -1988) (11), 11% (1986 -1992) (21), 17.5% (1986 -1991) (22) and 15.6% (1982-1990) (4) , although in the latter study, the mortality rate decreased to 8.3% during the last 4 years. Series before 1982 have shown higher mortality rates, varying from 11% (12) to 42% (13) , with most series having early mortality rates of more than 25% (13, 14, 18, 19, 24) . This trend toward decreasing mortality with time was observed in our large series. Hospital mortality improved significantly with subsequent birth cohorts, although it still remained high-41% for the last birth cohort (1988 -1997) . During 1996 -1997, however, hospital mortality further declined to 18%, which is comparable with contemporary reports.
Factors associated with mortality after PTA repair. We noted only one significant factor associated with increased mortality before hospital discharge after PTA repairearlier date of surgical repair in the overall experience. Age at repair was not significantly related to hospital mortality. Although these findings are comparable with those of some studies (3, 17, 21) , Lacour-Gayet et al. (20) have reported that age younger than one month remains an incremental risk factor. Others have reported that increasing age was a risk factor for hospital mortality (18, 22) . Previous palliative surgeries performed on patients that subsequently went on to have PTA repair did not significantly increase hospital mortality. However, it must be mentioned that in our experience, 8 (73%) of the 11 patients that had repair after a palliative procedure did not survive to hospital discharge.
The presence of interruption of the aortic arch has been previously reported to be a risk factor for mortality. Pearl et al. (4) reported that the presence of interruption of the aortic arch increased early mortality with PTA repair. Bove et al. (21) reported that associated cardiac defects were not significantly associated with increased mortality. We likewise did not identify an association between other cardiac defects and hospital mortality. This is in contrast with the series reported by Hanley et al. (22) in which interruption of the aortic arch was a significant risk factor for mortality after PTA repair.
Conduit reoperations. Thirty-four patients underwent 42 conduit replacements. There was one hospital death after replacement. Smaller conduit size was a significant factor associated with a shorter time to initial conduit reoperation. Use of a pulmonary homograft versus an aortic homograft or a xenograft was associated with greater initial conduit longevity. Heinemann et al. (25) noted similar results. They noted that the use of aortic homografts are a significant risk factor for early replacement and encouraged the use of a pulmonary homograft. There are many advantages in using a pulmonary homograft (26) . However, Morshuis et al. (27) reported the use of a pulmonary homograft in the reconstruction of PTA in an infant, with severe conduit valve (19) noted similar results on early mortality, but assert that significant truncal valve regurgitation complicates the operative and the early postoperative course. Our study, similarly, did not show a significant relation between hospital mortality after PTA repair and the preoperative degree of truncal valve regurgitation. As patients with important truncal valve dysfunction often undergo truncal valve repair or replacement, controversy exists as to whether the observed increased mortality at PTA repair is associated with valve repair or replacement or the presence of prerepair regurgitation. In our series, truncal valve replacement at time of repair was performed for six patients-three of whom had mild truncal valve regurgitation (one hospital death, and one late death 9 months after surgery), one moderate and two with severe regurgitation (both died before hospital discharge). This represents a total mortality rate of 67%. Brizard et al. (17) reported that mortality related to replacement or repair of the truncal valve at repair may explain the finding of truncal valve regurgitation as a risk factor for hospital mortality. McElhinney et al. (14) also report a high mortality after truncal valve replacement. In their series of seven patients who had replacement of their valve, 5 died early and 2 patients died late after the operation. One of the late deaths occurred 8 months after initial truncal valve replacement and two months after a second valve replacement was performed. All but 1 of the 7 patients had severe truncal valve regurgitation preoperatively. In our series, 5 truncal valve replacements 
